Fig. 7.
Whole body pharmacokinetic clearance of 125I-labeled chCLL-1, chCLL-1/GM-CSF, and chCLL-1/IL-2 in nontumor-bearing mice. Activity at injection and at selected times thereafter was measured with a microdosimeter.
Whole body pharmacokinetic clearance of 125I-labeled chCLL-1, chCLL-1/GM-CSF, and chCLL-1/IL-2 in nontumor-bearing mice. Activity at injection and at selected times thereafter was measured with a microdosimeter.
